Biotech, Diagnostics, Life Sciences

Isis Subsidiary Receives Grants, Contracts Worth $8.4 Million

Luke Timmerman 10/3/08

Isis Pharmaceuticals said today that its diagnostic subsidiary, Ibis Biosciences, was awarded federal grants and contracts worth as much as $8.4 million. The Carlsbad, CA-based company (NASDAQ: ISIS) said its subsidiary got the grants and contracts from the U.S. Department of Agriculture, National Institute of Justice, and other agencies. The company is being asked to help identify flu viruses, other pathogens, and offer improved forensics.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can email him at ltimmerman@xconomy.com or call 206-624-2374.